AbbVie
ABBV
#27
Rank
$337.52 B
Marketcap
$191.08
Share price
-0.70%
Change (1 day)
12.61%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of March 2025 : $134.70 Billion USD

According to AbbVie's latest financial reports the company's total liabilities are $134.70 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$131.79 B6.02%
2023-12-31$124.31 B2.3%
2022-12-31$121.51 B-7.3%
2021-12-31$131.09 B-4.64%
2020-12-31$137.46 B41.3%
2019-12-31$97.28 B43.5%
2018-12-31$67.79 B3.21%
2017-12-31$65.68 B6.88%
2016-12-31$61.46 B25.17%
2015-12-31$49.10 B90.54%
2014-12-31$25.77 B4.31%
2013-12-31$24.70 B4.49%
2012-12-31$23.64 B211.57%
2011-12-31$7.58 B39.72%
2010-12-31$5.43 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
$117.39 B-12.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$74.97 B-44.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$73.54 B-45.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$83.16 B-38.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$37.35 B-72.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$11.05 B-91.79%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$60.87 B-54.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
$65.12 B-51.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
$1.15 B-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA